If it was possible to accelerate drug discovery by looking at computed protein structures rather than protein structures established experimentally, it has now become plausible to do so. It has crossed a tipping point.
Since I'm not aware that there has been any drug discovery that has strongly depended on computational protein folding, this possible benefit remains to be seen.
[I worked in a lab which was heavily involved in CASP, the protein folding competition, but I was not myself involved]
Even though Google only won 4/5 games against Lee Sedol, that was the moment that sticks in peoples minds as when Google solved the problem of computer Go. What happened afterwards was a process of perfecting the algorithm. It seems likely the next few years will bring the same for AlphaFold.
https://twitter.com/TassosPerrakis/status/133353559400213299...
Tassos is also a professor in structural biology. Discovering structures the experimental way.
EDIT: on the other hand he also agrees that it's not the end of experimental structural biology
https://twitter.com/TassosPerrakis/status/133402467831107993...
This seems to be the core of the article's arguments. Is this ratio high enough to claim the problem is "solved"?